Condition
Malignant (Pleural) Mesothelioma
Estimated Enrollment: 10
Age Group: Child, Adult, Senior
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NL24050.000.08
Study First Received: June 1, 2010
Last Updated: February 26, 2014
Estimated Primary Completion Date: October 2011
Primary Outcome Measures:
number of cytotoxic T cells and regulatory T cells in the blood of patients|safety and toxicity
Sponsors and Collaborators:
Erasmus Medical Center
Website Link: https://ClinicalTrials.gov/show/NCT01241682
